Prospective assessment of platelet function in patients undergoing elective resection of glioblastoma multiforme

References

• Wun T, White RH. Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol. 2009;22:9–11. doi:10.1016/j.beha.2008.12.001.
   PubMed Web of Science ®Google Scholar
• Timp JF, Braekkand SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122:1712–23. doi:10.1182/blood-2013-04-460121.
   PubMed Web of Science ®Google Scholar
• Mandoj C, Tomao L, Conti L. Coagulation in brain tumors: biological basis and clinical implications. Front Neurol. 2019;10:181. doi:10.3389/fneur.2019.00181.
   PubMed Web of Science ®Google Scholar
• Ay C, Vormittag R, Dunkler D, Simanek R, Chiriac AL, Drach J, Quehenberger P, Wagner O, Zielinski C, Pabinger I. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study. J Clin Oncol. 2009;27:4124–9. doi:10.1200/JCO.2008.21.7752.
   PubMed Web of Science ®Google Scholar
• Pace A, Mandoj C, Antenucci A, Villani V, Sperduti I, Casini B, Carosi M, Fabi A, Vidiri A, Koudriavtseva T, et al. A predictive value of von willebrand factor for early response to bevacizumab therapy in recurrent glioma. J Neurooncol. 2018;138:527–35. doi:10.1007/s11060-018-2820-x.
   PubMed Web of Science ®Google Scholar
• Brockmann MA, Giese A, Mueller K, Kaba FJ, Lohr F, Weiss C, Gottschalk S, Nolte I, Leppert J, Tuettenberg J, et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma. Neuro Oncol. 2007;9:335–42. doi:10.1215/15228517-2007-013.
   PubMed Web of Science ®Google Scholar
• Gaist D, Garcia-Rodriguez LA, Sorensen HT, Hallas J, Friis S. Use of low-dose aspirin and non-aspirin nonsteroidal anti-inflammatory drugs and risk of glioma: a case-control study. Br J Cancer. 2013;108:1189–94. doi:10.1038/bjc.2013.87.
   PubMed Web of Science ®Google Scholar
• Riedl J, Preusser M, Nazari PM, Posch F, Panzer S, Marosi C, Birner P, Thaler J, Brostjan C, Lötsch D, et al. Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. Blood. 2017;129:1831–9. doi:10.1182/blood-2016-06-720714.
   PubMed Web of Science ®Google Scholar
• Maegele M, Schöchl H, Menovsky T, Maréchal H, Marklund N, Buki A, Stanworth S. Coagulopathy and haemorrhagic progression in traumatic brain injury: advances in mechanisms, diagnosis, and management. Lancet Neurol. 2017;16:630–47. doi:10.1016/S1474-4422(17)30197-7.
   PubMed Web of Science ®Google Scholar
• Kvint S, Schuster J, Kumar MA. Neurosurgical applications of viscoelastic hemostatic assays. Neurosurg Focus. 2017;43:E9. doi:10.3171/2017.8.FOCUS17447.
   PubMed Web of Science ®Google Scholar
• Frontera JA, Provencio JJ, Sehba FA, McIntyre TM, Nowacki AS, Gordon E, Weimer JM, Aledort, Aledort L. The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage. Neurocrit Care. 2017;26:48–57. doi:10.1007/s12028-016-0292-4.
   PubMed Web of Science ®Google Scholar
• Tutwiler V, Peshkova AD, Andrianova IA, Khasanova DR, Weisel JW, Litvinov RI. Contraction of blood clots is impaired in acute ischemic stroke. Arterioscler Thromb Vasc Biol. 2017;37:271–9. doi:10.1161/ATVBAHA.116.308622.
   PubMed Web of Science ®Google Scholar
• Jurk K, Jahn UR, Van Aken H, Schriek C, Droste DW, Ritter MA, Bernd Ringelstein E, Kehrel BE. Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-1). Thromb Haemost. 2004;91:334–44. doi:10.1160/TH03-01-0044.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang F, Dong JF. Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood. 2018;131:2001–6. doi:10.1182/blood-2017-11-784108.
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Mysliwiec M, Matuszewska E, Sulkowski S, Zimnoch L, Politynska B, Wojtukiewicz AM, Tucker SC, Honn KV. Imbalance in coagulation/fibrinolysis inhibitors resulting in extravascular thrombin generation in gliomas of varying levels of malignancy. Biomolecules. 2021;11:663. doi:10.3390/biom11050663.
   PubMed Web of Science ®Google Scholar
• Navone SE, Guarnaccia L, Locatelli M, Rampini P, Caroli M, La Verde N, Gaudino C, Bettinardi N, Riboni L, Marfia G, et al. Significance and prognostic value of the coagulation profile in patients with glioblastoma: implications for personalized therapy. World Neurosurg. 2019;121:e621–9. doi:10.1016/j.wneu.2018.09.177.
   PubMed Web of Science ®Google Scholar
• Zhao L, Bi Y, Kou J, Shi J, Piao D. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients. J Exp Clin Cancer Res. 2016;35:54. doi:10.1186/s13046-016-0328-9.
   PubMed Web of Science ®Google Scholar
• Leiva O, Connors JM, Al-Samkari H. Impact of tumor genomic mutations on thrombotic risk in cancer patients. Cancers (Basel). 2020;12:1958. doi:10.3390/cancers12071958.
   PubMed Web of Science ®Google Scholar
• Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg. 2011;35:881–7. doi:10.1007/s00268-011-0957-2.
   PubMed Web of Science ®Google Scholar
• Petricevic M, Konosic S, Biocina B, Dirkmann D, White A, Mihaljevic MZ, Ivancan V, Konosic L, Svetina L, Görlinger K, et al. Bleeding risk assessment in patients undergoing elective cardiac surgery using ROTEM(®) platelet and Multiplate(®) impedance aggregometry. Anaesthesia. 2016;71:636–47. doi:10.1111/anae.13303.
   PubMed Web of Science ®Google Scholar
• Curry NS, Davenport R, Pavord S, Mallett SV, Kitchen D, Klein AA, Maybury H, Collins PW, Laffan M. The use of viscoelastic haemostatic assays in the management of major bleeding: a British society for haematology guideline. Br J Haematol. 2018;182:789–806. doi:10.1111/bjh.15524.
   PubMed Web of Science ®Google Scholar
• Görlinger K, Pérez-Ferrer A, Dirkmann D, Saner F, Maegele M, Calatayud ÁAP, Kim TY. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 2019;72:297–322. doi:10.4097/kja.19169.
   PubMed Web of Science ®Google Scholar
• Leal-Noval SR, Fernández-Pacheco J, Casado-Méndez M, Cancela P, Narros JL, Arellano-Orden V, Dusseck R, Díaz-Martín A, Muñoz-Gómez M. A prospective study on the correlation between thromboelastometry and standard laboratory tests - influence of type of surgery and perioperative sampling times. Scand J Clin Lab Invest. 2020;80:179–84. doi:10.1080/00365513.2019.1704051.
   PubMed Web of Science ®Google Scholar
• Gomez-Builes JC, Acuna SA, Nascimento B, Madotto F, Rizoli SB. Harmful or physiologic: diagnosing fibrinolysis shutdown in a trauma cohort with rotational thromboelastometry. Anesth Analg. 2018;127:840–9. doi:10.1213/ANE.0000000000003341.
   PubMed Web of Science ®Google Scholar
• Stettler GR, Moore EE, Moore HB, Nunns GR, Silliman CC, Banerjee A, Sauaia A. Redefining postinjury fibrinolysis phenotypes using two viscoelastic assays. J Trauma Acute Care Surg. 2019;86:679–85. doi:10.1097/TA.0000000000002165.
   PubMed Web of Science ®Google Scholar
• Kruse JM, Magomedov A, Kurreck A, Münch FH, Koerner R, Kamhieh-Milz J, Kahl A, Gotthardt I, Piper SK, Eckardt KU, et al. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit Care. 2020;24:676. doi:10.1186/s13054-020-03401-8.
   PubMed Web of Science ®Google Scholar
• Goh KY, Tsoi WC, Feng CS, Wickham N, Poon WS. Haemostatic changes during surgery for primary brain tumours. J Neurol Neurosurg Psychiatry. 1997;63:334–8. doi:10.1136/jnnp.63.3.334.
   PubMed Web of Science ®Google Scholar
• Jansohn E, Bengzon J, Kander T, Schött U. A pilot study on the applicability of thromboelastometry in detecting brain tumour-induced hypercoagulation. Scand J Clin Lab Invest. 2017;77:289–94. doi:10.1080/00365513.2017.1306877.
   PubMed Web of Science ®Google Scholar
• Kim OV, Nevzorova TA, Mordakhanova ER, Ponomareva AA, Andrianova IA, Le Minh G, Daminova AG, Peshkova AD, Alber MS, Vagin O, et al. Fatal dysfunction and disintegration of thrombin-stimulated platelets. Haematologica. 2019;104:1866–78. doi:10.3324/haematol.2018.202309.
   PubMed Web of Science ®Google Scholar
• Nolte I, Przibylla H, Bostel T, Groden C, Brockmann MA. Tumor-platelet interactions: glioblastoma growth is accompanied by increasing platelet counts. Clin Neurol Neurosurg. 2008;110:339–42. doi:10.1016/j.clineuro.2007.12.008.
   PubMed Web of Science ®Google Scholar
• Campanella R, Guarnaccia L, Cordiglieri C, Trombetta E, Caroli M, Carrabba G, La Verde N, Rampini P, Gaudino C, Costa A, et al. Tumor-educated platelets and angiogenesis in glioblastoma: another brick in the wall for novel prognostic and targetable biomarkers, changing the vision from a localized tumor to a systemic pathology. Cells. 2020;9:294. doi:10.3390/cells9020294.
   PubMed Web of Science ®Google Scholar
• Llompart-Pou JA, Barea-Mendoza JA, Pérez-Bárcena J, Sánchez-Casado M, Ballesteros-Sanz MA, Chico-Fernández M. Survey of the neurocritical patient care in Spain. Part 1: trauma of the central nervous system. Med Intensiva (Engl Ed). 2021;45:250–2. doi:10.1016/j.medin.2019.09.001.
   PubMed Web of Science ®Google Scholar
• Riedl J, Kaider A, Marosi C, Prager G, Eichelberger B, Koder S, Panzer S, Pabinger I, Ay C. Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis. Thromb Res. 2016;140(Suppl 1):S199–200. doi:10.1016/S0049-3848(16)30196-7.
   PubMedGoogle Scholar
• Hoke M, Dieckmann K, Koppensteiner R, Schillinger M, Marosi C, Mlekusch W. Prognostic value of plasma d-dimer levels in patients with glioblastoma multiforme - results from a pilot study. Wien Klin Wochenschr. 2011;123:199–203. doi:10.1007/s00508-011-1556-9.
   PubMed Web of Science ®Google Scholar
• Moreno G, Carbonell R, Bodí M, Rodríguez A. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Med Intensiva (Engl Ed). 2021;45:42–55. doi:10.1016/j.medin.2020.06.006.
   PubMedGoogle Scholar
• Gabara C, Solarat B, Castro P, Fernández S, Badia JR, Toapanta D, Schulman S, Reverter JC, Soriano A, Moisés J, et al. Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients. Med Intensiva (Engl Ed). 2021;30:S0210-5691(21)00178–9. English, Spanish. doi:10.1016/j.medin.2021.07.004.
   Google Scholar